http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2597863-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
| filingDate | 2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a3ef3494bc6a8c2d5d2531f338eba0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f8eb9083a760f715a6fc9f2103e5e3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf9ffad63310e09d9c13acdf43cae49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9098f175c5af0be15454efd460751da0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bdc162c88345e2f2f04e5f99a5bd474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8552c42d88f92d5c3ad06e6b207ff32 |
| publicationDate | 2017-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2597863-T3 |
| titleOfInvention | Substituted triazine derivatives and their use as stimulators of soluble guanylate cyclase |
| abstract | Compound of formula (I) ** Formula ** in which ring Q represents a group of formula ** Formula ** in which * represents the -CH2-R2 binding site, ** represents the site of binding to triazine ring, R1a represents hydrogen or fluorine, R1b represents hydrogen or methyl, R2 represents 3,3,3-trifluoroprop-1-yl, 2,2,3,3-tetrafluoroprop-1-yl, 2,2,3, 3,3-pentafluoroprop-1-yl, phenyl or pyridyl, with phenyl being substituted with 1 to 3 fluoro substituents and pyridyl being substituted with 1 fluoro substituent, R3 represents difluoromethyl, trifluoromethyl, (C1-C6) alkyl, cyclopropyl, cyclobutyl, cyclopentyl, methylsulfonylamino, methoxycarbonylamino, phenyl, pyrazolyl, oxazolyl, or pyridyl, and C1-C6-alkyl may be substituted with 1 to 3 substituents independently selected from the group of fluorine, trifluoromethyl, cyclopropyl, cyclobutyl, cyclopentyl, difluororomethoxy, , methoxy and ethoxy, and may be substituted f enyl, pyrazolyl, oxazolyl, and pyridyl with 1 or 2 substituents independently selected from the group of fluorine, chlorine, difluoromethyl, trifluoromethyl, methyl, ethyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethoxy, methoxy and ethoxy, R4 represents hydroxyl or amino, thus like its salts, solvates and solvates of salts. |
| priorityDate | 2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.